Many cancer patients go on to develop heart failure - because of the cancer itself and also due to chemotherapy. But a new ...

Research shows that a common type of diabetes medication could help cancer patients make a better long-term recovery. Many cancer patients go on to develop heart failure -- because of the cancer ...

A widely used diabetes medication, SGLT2 inhibitors, has shown a surprising benefit for cancer patients—protecting their ...

Mankind Pharma and other domestic companies have launched generic versions of the popular diabetes drug Empagliflozin at ...

A common type of diabetes medication could help cancer patients make a better long-term recovery, according to new research from the University of East Anglia.

Indian drug companies are set to revolutionize diabetes treatment with affordable generic versions of Empagliflozin, ...

A commonly used diabetes medication could improve long-term recovery for cancer patients, according to research from the University of East Anglia. Many cancer patients go on to develop heart ...

Glenmark Pharmaceuticals on Wednesday said it has launched a medication for glycemic control and weight-loss for diabetes ...

Generic versions of diabetes drug Empagliflozin launched in India, crashing prices by 80-90% on day one post-patent expiry.

Glenmark Pharmaceuticals launches Empagliflozin, an SGLT2 inhibitor, in India under the brand name Glempa for glycemic ...

Alkem Laboratories has launched a generic medication for type-2 diabetes, chronic kidney disease and heart failure in India ...